<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02574312</url>
  </required_header>
  <id_info>
    <org_study_id>10002</org_study_id>
    <nct_id>NCT02574312</nct_id>
  </id_info>
  <brief_title>ATTUNE Single-Use Instrumentation vs. ATTUNE Reusable Instrumentation in Primary Total Knee Arthroplasty</brief_title>
  <acronym>SOLO</acronym>
  <official_title>Comparison of Alignment Achieved Using Single-Use Versus Reusable Instrumentation in Total Knee Arthroplasty (TKA): A Prospective, Non-Randomized Multi-center Investigation</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>DePuy Orthopaedics</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>DePuy Orthopaedics</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      This post-marketing investigation will evaluate the mechanical axis alignment achieved with
      the ATTUNE Single-Use Instrumentation (SUI) as compared to the mechanical axis alignment
      achieved with the ATTUNE Reusable Instrumentation (RUI) in primary cemented Total Knee
      Arthroplasty.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      This study is designed as comparative, sequential, non-randomized, multi-center
      investigation.

      Up to four sites will recruit approximately 88 subjects. Each site is expected to implant the
      ATTUNE primary cemented total knee in approximately 22 subjects. The sequential design
      requires all ATTUNE TKA with reusable instruments be completed before doing any ATTUNE TKA
      with single use instruments.

      The mechanical axis alignment will be assessed at the 3 month follow-up by independent
      radiographic review.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">October 1, 2015</start_date>
  <completion_date type="Actual">March 28, 2019</completion_date>
  <primary_completion_date type="Actual">March 28, 2019</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Non-Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single (Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Difference in Absolute Mechanical Axis Alignment Angle Between Subjects Operated on With RUI and SUI TKA Instrumentation</measure>
    <time_frame>3 Months Post Surgery</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Femoral Component Varus Valgus Angle Between Subjects Operated on With RUI and SUI TKA Instrumentation</measure>
    <time_frame>3 Months Post Surgery</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Tibial Component Varus Valgus Angle Between Subjects Operated on With RUI and SUI TKA Instrumentation</measure>
    <time_frame>3 Months Post Surgery</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Femoral Component Flexion Angle Between Subjects Operated on With RUI and SUI Instrumentation</measure>
    <time_frame>3 Months Post Surgery</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Posterior Tibial Slope Between Subjects Operated on With RUI and SUI Instrumentation</measure>
    <time_frame>3 Months Post Surgery</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Number of Participants With Treatment-related Adverse Events</measure>
    <time_frame>3 Months Post Surgery</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">88</enrollment>
  <condition>Osteoarthritis</condition>
  <condition>Post-traumatic Arthritis</condition>
  <arm_group>
    <arm_group_label>TKA with RUI</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>44 Subjects will receive TKA with RUI per their study doctor's standard of care. These 44 subjects will receive the TKA using Reusable instruments (RUI).</description>
  </arm_group>
  <arm_group>
    <arm_group_label>TKA with SUI</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>44 Subjects will receive TKA with SUI per their study doctor's standard of care. These 44 subjects will receive the TKA using Single Use Instruments (SUI).</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>ATTUNE TKA with ATTUNE RUI</intervention_name>
    <description>ATTUNE TKA with ATTUNE RUI</description>
    <arm_group_label>TKA with RUI</arm_group_label>
    <other_name>ATTUNE Intuition</other_name>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>ATTUNE TKA with ATTUNE SUI</intervention_name>
    <description>ATTUNE TKA with ATTUNE SUI</description>
    <arm_group_label>TKA with SUI</arm_group_label>
    <other_name>ATTUNE SOLO</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          1. Subjects with severely painful and/or severely disabling Non-inflammatory Degenerative
             Joint Disease (NIDJD) resulting from osteoarthritis (OA) or post-traumatic arthritis.

          2. Subject is male or female and between the ages of 22 and 80 years old, inclusive.

          3. Subject requires a primary total knee replacement and is considered by the
             Investigator to be suitable for the specific knee prosthesis identified in the
             protocol.

          4. Subject, who, in the opinion of the Investigator, is suitable for implantation using
             either RUI or SUI instrumentation.

          5. Subject is able to speak and read English to facilitate comprehension of the Informed
             Consent Document.

          6. Subject has given voluntary, written informed consent to participate in this clinical
             investigation and has authorized the transfer of his/her information to DePuy Synthes
             Joint Reconstruction.

          7. Subject, in the opinion of the Investigator, is able to understand this clinical
             investigation and is willing and able to perform all study procedures and follow-up
             visits and co-operate with investigational procedures.

        Exclusion Criteria:

          1. The Subject has, in the opinion of the Investigator, a severe deformity that will
             hinder achieving a mechanical axis alignment target of 0° ± 3°.

          2. The Subject has, in the opinion of the Investigator, an existing condition that would
             compromise their participation and follow-up in this study.

          3. The Subject has, in the opinion of the Investigator, a flexion deformity that will not
             allow for 0° extension postoperatively.

          4. The Subject is a woman who is pregnant or lactating.

          5. The Subject, in the opinion of the Investigator, is a drug or alcohol abuser (in the
             last 5 years) or has a psychological disorder that could affect follow-up care or
             treatment outcomes.

          6. The Subject has participated in a clinical investigation with an investigational
             product in the last 3 months.

          7. The Subject is currently involved in any personal injury litigation, medical-legal or
             worker's compensations claims.

          8. The Subject has previous prosthetic knee replacement (any type including
             unicompartmental, total knee arthroplasty, patellofemoral arthroplasty or ipsilateral
             UTO/HTO) of the affected knee or a previous patellectomy.

          9. The Subject presents with ankylosis of the hip joint on the side to be treated.

         10. The Subject had a contralateral TKA and that knee was previously entered into the
             study.

         11. The Subject requires simultaneous bilateral total knee replacements.

         12. Any case in which Computer-Assisted Surgery (CAS) or TruMatch (or any other type of
             Custom Patient Instruments) is to be used, or any additional instrumentation are to be
             used for bone resections that are not provided as part of the ATTUNE RUI or SUI
             Instrument kits.

         13. The Subject requires a device not specified in the protocol or the surgeon determines
             that the ATTUNE Knee System is not a suitable treatment.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>22 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Verdonna Huey, MS,BSN,CCRP</last_name>
    <role>Study Director</role>
    <affiliation>DePuy Synthes</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Scripps Clinic Torrey Pines</name>
      <address>
        <city>La Jolla</city>
        <state>California</state>
        <zip>92037</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Geisinger Wyoming Valley</name>
      <address>
        <city>Wilkes-Barre</city>
        <state>Pennsylvania</state>
        <zip>18702</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Spire Liverpool Hospital</name>
      <address>
        <city>Liverpool</city>
        <zip>L18 1HQ</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Clifton Park Hospital</name>
      <address>
        <city>York</city>
        <zip>YO30 5RA</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United Kingdom</country>
    <country>United States</country>
  </location_countries>
  <verification_date>March 2020</verification_date>
  <study_first_submitted>September 30, 2015</study_first_submitted>
  <study_first_submitted_qc>October 9, 2015</study_first_submitted_qc>
  <study_first_posted type="Estimate">October 12, 2015</study_first_posted>
  <results_first_submitted>March 27, 2020</results_first_submitted>
  <results_first_submitted_qc>March 27, 2020</results_first_submitted_qc>
  <results_first_posted type="Actual">April 9, 2020</results_first_posted>
  <last_update_submitted>March 27, 2020</last_update_submitted>
  <last_update_submitted_qc>March 27, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">April 9, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Mechanical Axis Alignment</keyword>
  <keyword>Knee Arthroplasty, Total</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Osteoarthritis</mesh_term>
  </condition_browse>
  <provided_document_section>
    <provided_document>
      <document_type>Study Protocol</document_type>
      <document_has_protocol>Yes</document_has_protocol>
      <document_has_icf>No</document_has_icf>
      <document_has_sap>No</document_has_sap>
      <document_date>February 19, 2018</document_date>
      <document_url>https://ClinicalTrials.gov/ProvidedDocs/12/NCT02574312/Prot_000.pdf</document_url>
    </provided_document>
    <provided_document>
      <document_type>Statistical Analysis Plan</document_type>
      <document_has_protocol>No</document_has_protocol>
      <document_has_icf>No</document_has_icf>
      <document_has_sap>Yes</document_has_sap>
      <document_date>May 6, 2019</document_date>
      <document_url>https://ClinicalTrials.gov/ProvidedDocs/12/NCT02574312/SAP_001.pdf</document_url>
    </provided_document>
  </provided_document_section>

  <clinical_results>

    <participant_flow>
      <recruitment_details>The first patient was operated on 16 November 2015 and recruitment lasted for 37 months with the last patient operated on 19 December 2018.</recruitment_details>
      <pre_assignment_details>Consent was taken for 102 knees, 14 subjects were deemed ineligible for the study. This left 88 subjects in the safety population that could be randomised for the study.</pre_assignment_details>
      <group_list>
        <group group_id="P1">
          <title>RUI (Reuseable Instrumentation)</title>
          <description>Patients were operated on using Reusable TKA Instrumentation</description>
        </group>
        <group group_id="P2">
          <title>SUI (Single-Use Instrumentation)</title>
          <description>Patients were operated on using Single-Use TKA Instrumentation</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Pre-Operative</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="44"/>
                <participants group_id="P2" count="44"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="44"/>
                <participants group_id="P2" count="44"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="0"/>
              </participants_list>
            </milestone>
          </milestone_list>
        </period>
        <period>
          <title>3 Months Follow-up</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="44"/>
                <participants group_id="P2" count="44"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="43">One subject withdrew consent</participants>
                <participants group_id="P2" count="44"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="1"/>
                <participants group_id="P2" count="0"/>
              </participants_list>
            </milestone>
          </milestone_list>
          <drop_withdraw_reason_list>
            <drop_withdraw_reason>
              <title>Withdrawal by Subject</title>
              <participants_list>
                <participants group_id="P1" count="1"/>
                <participants group_id="P2" count="0"/>
              </participants_list>
            </drop_withdraw_reason>
          </drop_withdraw_reason_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <population>All subjects who received the study device.</population>
      <group_list>
        <group group_id="B1">
          <title>RUI (Reuseable Instrumentation)</title>
          <description>Patients were operated on using Reusable TKA Instrumentation</description>
        </group>
        <group group_id="B2">
          <title>SUI (Single-Use Instrumentation)</title>
          <description>Patients were operated on using Single-Use TKA Instrumentation</description>
        </group>
        <group group_id="B3">
          <title>Total</title>
          <description>Total of all reporting groups</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="44"/>
            <count group_id="B2" value="44"/>
            <count group_id="B3" value="88"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>years</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="66.0" spread="6.89"/>
                    <measurement group_id="B2" value="69.3" spread="7.98"/>
                    <measurement group_id="B3" value="67.9" spread="8.0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Sex: Female, Male</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>Female</title>
                  <measurement_list>
                    <measurement group_id="B1" value="20"/>
                    <measurement group_id="B2" value="26"/>
                    <measurement group_id="B3" value="46"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Male</title>
                  <measurement_list>
                    <measurement group_id="B1" value="24"/>
                    <measurement group_id="B2" value="18"/>
                    <measurement group_id="B3" value="42"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Ethnicity (NIH/OMB)</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>Hispanic or Latino</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Not Hispanic or Latino</title>
                  <measurement_list>
                    <measurement group_id="B1" value="22"/>
                    <measurement group_id="B2" value="22"/>
                    <measurement group_id="B3" value="44"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Unknown or Not Reported</title>
                  <measurement_list>
                    <measurement group_id="B1" value="22"/>
                    <measurement group_id="B2" value="22"/>
                    <measurement group_id="B3" value="44"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Region of Enrollment</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <title>United Kingdom</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="22"/>
                    <measurement group_id="B2" value="22"/>
                    <measurement group_id="B3" value="44"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>United States</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="22"/>
                    <measurement group_id="B2" value="22"/>
                    <measurement group_id="B3" value="44"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Difference in Absolute Mechanical Axis Alignment Angle Between Subjects Operated on With RUI and SUI TKA Instrumentation</title>
        <time_frame>3 Months Post Surgery</time_frame>
        <population>All patients with readable radiographs who were enrolled without major protocol violations</population>
        <group_list>
          <group group_id="O1">
            <title>RUI (Reuseable Instrumentation)</title>
            <description>Patients were operated on using Reusable TKA Instrumentation</description>
          </group>
          <group group_id="O2">
            <title>SUI (Single-Use Instrumentation)</title>
            <description>Patients were operated on using Single-Use TKA Instrumentation</description>
          </group>
        </group_list>
        <measure>
          <title>Difference in Absolute Mechanical Axis Alignment Angle Between Subjects Operated on With RUI and SUI TKA Instrumentation</title>
          <population>All patients with readable radiographs who were enrolled without major protocol violations</population>
          <units>Degrees</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <units_analyzed>Radiographs</units_analyzed>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="34"/>
                <count group_id="O2" value="41"/>
              </count_list>
            </analyzed>
            <analyzed>
              <units>Radiographs</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="34"/>
                <count group_id="O2" value="41"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2.55" spread="2.44"/>
                    <measurement group_id="O2" value="2.97" spread="2.33"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Non-Inferiority</non_inferiority_type>
            <non_inferiority_desc>Non-Inferiority Analysis of absolute value of mechanical axis alignment with NI margin of 1.5 degrees, using a 1-sided T-test with alpha of 0.05. Anticipated power was 95%.</non_inferiority_desc>
            <p_value>0.028</p_value>
            <method>t-test, 1 sided</method>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Femoral Component Varus Valgus Angle Between Subjects Operated on With RUI and SUI TKA Instrumentation</title>
        <time_frame>3 Months Post Surgery</time_frame>
        <population>All patients with readable radiographs who were enrolled without major protocol violations</population>
        <group_list>
          <group group_id="O1">
            <title>RUI (Reuseable Instrumentation)</title>
            <description>Patients were operated on using Reusable TKA Instrumentation</description>
          </group>
          <group group_id="O2">
            <title>SUI (Single-Use Instrumentation)</title>
            <description>Patients were operated on using Single-Use TKA Instrumentation</description>
          </group>
        </group_list>
        <measure>
          <title>Femoral Component Varus Valgus Angle Between Subjects Operated on With RUI and SUI TKA Instrumentation</title>
          <population>All patients with readable radiographs who were enrolled without major protocol violations</population>
          <units>Degrees</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <units_analyzed>Radiographs</units_analyzed>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="34"/>
                <count group_id="O2" value="41"/>
              </count_list>
            </analyzed>
            <analyzed>
              <units>Radiographs</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="34"/>
                <count group_id="O2" value="41"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="94.9" spread="2.10"/>
                    <measurement group_id="O2" value="95.8" spread="2.40"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Tibial Component Varus Valgus Angle Between Subjects Operated on With RUI and SUI TKA Instrumentation</title>
        <time_frame>3 Months Post Surgery</time_frame>
        <population>All patients with readable radiographs who were enrolled without major protocol violations</population>
        <group_list>
          <group group_id="O1">
            <title>RUI (Reuseable Instrumentation)</title>
            <description>Patients were operated on using Reusable TKA Instrumentation</description>
          </group>
          <group group_id="O2">
            <title>SUI (Single-Use Instrumentation)</title>
            <description>Patients were operated on using Single-Use TKA Instrumentation</description>
          </group>
        </group_list>
        <measure>
          <title>Tibial Component Varus Valgus Angle Between Subjects Operated on With RUI and SUI TKA Instrumentation</title>
          <population>All patients with readable radiographs who were enrolled without major protocol violations</population>
          <units>Degrees</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <units_analyzed>Radiographs</units_analyzed>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="34"/>
                <count group_id="O2" value="41"/>
              </count_list>
            </analyzed>
            <analyzed>
              <units>Radiographs</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="34"/>
                <count group_id="O2" value="41"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="88.4" spread="2.18"/>
                    <measurement group_id="O2" value="88.7" spread="2.23"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Femoral Component Flexion Angle Between Subjects Operated on With RUI and SUI Instrumentation</title>
        <time_frame>3 Months Post Surgery</time_frame>
        <population>All patients with readable radiographs who were enrolled without major protocol violations</population>
        <group_list>
          <group group_id="O1">
            <title>RUI (Reuseable Instrumentation)</title>
            <description>Patients were operated on using Reusable TKA Instrumentation</description>
          </group>
          <group group_id="O2">
            <title>SUI (Single-Use Instrumentation)</title>
            <description>Patients were operated on using Single-Use TKA Instrumentation</description>
          </group>
        </group_list>
        <measure>
          <title>Femoral Component Flexion Angle Between Subjects Operated on With RUI and SUI Instrumentation</title>
          <population>All patients with readable radiographs who were enrolled without major protocol violations</population>
          <units>Degrees</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <units_analyzed>Radiographs</units_analyzed>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="34"/>
                <count group_id="O2" value="41"/>
              </count_list>
            </analyzed>
            <analyzed>
              <units>Radiographs</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="34"/>
                <count group_id="O2" value="41"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="6.21" spread="2.70"/>
                    <measurement group_id="O2" value="7.91" spread="3.20"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Posterior Tibial Slope Between Subjects Operated on With RUI and SUI Instrumentation</title>
        <time_frame>3 Months Post Surgery</time_frame>
        <population>All patients with readable radiographs who were enrolled without major protocol violations</population>
        <group_list>
          <group group_id="O1">
            <title>RUI (Reuseable Instrumentation)</title>
            <description>Patients were operated on using Reusable TKA Instrumentation</description>
          </group>
          <group group_id="O2">
            <title>SUI (Single-Use Instrumentation)</title>
            <description>Patients were operated on using Single-Use TKA Instrumentation</description>
          </group>
        </group_list>
        <measure>
          <title>Posterior Tibial Slope Between Subjects Operated on With RUI and SUI Instrumentation</title>
          <population>All patients with readable radiographs who were enrolled without major protocol violations</population>
          <units>Degrees</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <units_analyzed>Radiographs</units_analyzed>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="34"/>
                <count group_id="O2" value="41"/>
              </count_list>
            </analyzed>
            <analyzed>
              <units>Radiographs</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="34"/>
                <count group_id="O2" value="41"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1.04" spread="2.49"/>
                    <measurement group_id="O2" value="0.78" spread="2.70"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Number of Participants With Treatment-related Adverse Events</title>
        <time_frame>3 Months Post Surgery</time_frame>
        <population>All subjects who received the study device</population>
        <group_list>
          <group group_id="O1">
            <title>RUI (Reuseable Instrumentation)</title>
            <description>Patients were operated on using Reusable TKA Instrumentation</description>
          </group>
          <group group_id="O2">
            <title>SUI (Single-Use Instrumentation)</title>
            <description>Patients were operated on using Single-Use TKA Instrumentation</description>
          </group>
        </group_list>
        <measure>
          <title>Number of Participants With Treatment-related Adverse Events</title>
          <population>All subjects who received the study device</population>
          <units>Participants</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="44"/>
                <count group_id="O2" value="44"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
    </outcome_list>

    <reported_events>
      <time_frame>All participants had reached the 3 month follow-up visit at the time of uploading adverse events.</time_frame>
      <desc>Final assessment of adverse events were classified by system organ class in lieu of specific adverse event terms.</desc>
      <group_list>
        <group group_id="E1">
          <title>RUI (Reuseable Instrumentation)</title>
          <description>Patients were operated on using Reusable TKA Instrumentation</description>
        </group>
        <group group_id="E2">
          <title>SUI (Single-Use Instrumentation)</title>
          <description>Patients were operated on using Single-Use TKA Instrumentation</description>
        </group>
      </group_list>
      <serious_events>
        <default_vocab>MedDRA 17.0</default_vocab>
        <default_assessment>Systematic Assessment</default_assessment>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, all-cause mortality</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="44"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="44"/>
              </event>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="44"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="44"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Musculoskeletal and connective tissue disorders</title>
            <event_list>
              <event>
                <sub_title>Musculoskeletal</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="44"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="44"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>0</frequency_threshold>
        <default_vocab>MedDRA 17.0</default_vocab>
        <default_assessment>Systematic Assessment</default_assessment>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="5" subjects_at_risk="44"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="44"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Immune system disorders</title>
            <event_list>
              <event>
                <sub_title>Immune System Disorder</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="44"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="44"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Infections and infestations</title>
            <event_list>
              <event>
                <sub_title>Infections and infestations</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="44"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="44"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Musculoskeletal and connective tissue disorders</title>
            <event_list>
              <event>
                <sub_title>Musculoskeletal</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="44"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="44"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Vascular disorders</title>
            <event_list>
              <event>
                <sub_title>Vascular</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="44"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="44"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>Principal Investigators are NOT employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>DePuy reserves the right to review the contents of publications in advance.The PI may freely disclose the trial results only after DePuy has been given the opportunity of reviewing the proposed results communications at least 30 days prior to the intended release.DePuy will advise the PI of any perceived errors,omissions or corrections but PI will retain final editorial control. In case of disagreement, DePuy and PI will make every effort to meet in order to discuss and resolve any issues.</restrictive_agreement>
    </certain_agreements>
    <point_of_contact>
      <name_or_title>Kirstin Cosgrove</name_or_title>
      <organization>DePuy Ortho Joint US</organization>
      <phone>800-827-7003</phone>
      <email>kcosgro1@its.jnj.com</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

